Search for Stocks /

💊 Zevra Director Gets Stock Options at ₹0 — Welcome to Pharma Boardroom Privilege

🟢 At a Glance:

  • 🎯 Director: John B. Bode
  • 🧾 Form Type: SEC Form 4 (filed May 30, 2025)
  • 🗓️ Grant Date: May 29, 2025
  • 💰 Transaction: 30,000 stock options awarded
  • ⚙️ Exercise Price: $8.62 (closing price on grant day)
  • 💸 Cost to Acquire: $0 (compensation-based grant)
  • 🗓️ Expiry: May 28, 2035

📜 Details of the Transaction

🧪 Detail💡 Description
CompanyZevra Therapeutics Inc. (ZVRA)
Reporting PersonJohn B. Bode (Director)
Type of SecurityStock Option (right to buy common stock)
Options Granted30,000 shares
Exercise Price$8.62/share
Vesting
Read Full 16 Point breakdown. Continue reading →
Members get full access to every article.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →

Leave a Reply